Home Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG (German Diabetes Society)- and AWMF (Association of the Scientific Medical Societies)-guidelines1)
Article
Licensed
Unlicensed Requires Authentication

Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG (German Diabetes Society)- and AWMF (Association of the Scientific Medical Societies)-guidelines1)

  • Theodor Koschinsky EMAIL logo and Peter B. Luppa EMAIL logo
Published/Copyright: June 22, 2013
Become an author with De Gruyter Brill

Abstract

New DDG (Deutsche Diabetes-Gesellschaft) and AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) guidelines have been established for the diagnosis of diabetes mellitus and gestational diabetes. These are relevant for blood glucose (BG) measurements with reference to: distinction from HbA1c measurements; replacement of capillary BG values by venous plasma-derived BG values; and complete preanalytical inhibition of glycolysis. For the first time, BG values derived from standardized unit-use reagents and their related test systems are accepted (with a mandatory external ring trial system), but only for the screening and diagnosis of gestational diabetes. The Gemeinsamer Bundesausschuss recently recommended a standardized examination of all pregnancies for gestational diabetes and commanded reimbursement of the related costs by health insurers. As there are more than 600,000 pregnancies per year in Germany, this updated diagnostic procedure will expand considerably. It will require considerable competence in clinical chemistry to translate the new guideline standards into the analytical as well as the preanalytical and logistical settings in cooperation with the involved outpatient physicians.

Reviewed Publication:

Luppa P.B.



Correspondence: Prof. Dr. Theodor Koschinsky, Heilmannstr. 25, 81479 Munich, Germany Tel.: 089 72719696 Prof. Dr. Peter B. Luppa, Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU München, Ismaninger Str. 22, 81675 Munich, Germany

  1. 1)

    Original German online version at: http://www.degruyter.com/view/j/labm.2012.36.issue-3/labmed-2011-0018/labmed-2011-0018.xml?format=INT.

    The German article was translated by Compuscript Ltd. and authorized by the authors.

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;33(Suppl 1):S62–9.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000286497100003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.2337/dc10-S062Search in Google Scholar PubMed PubMed Central

2. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166–74.10.1373/clinchem.2003.024802Search in Google Scholar PubMed

3. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.10.2337/dc09-9033Search in Google Scholar PubMed PubMed Central

4. Stellungnahme der Deutschen Diabetes Gesellschaft, diabetes DE und des Kompetenznetzes Diabetes mellitus zur Verwendung des HbA1c-Wertes als Biomarker zur Diabetesdiagnose (http://profi.diabetesde.org/stellungnahmen/hba1c_wertes_als_biomarker/). Last Accessed on 27 April 2012.Search in Google Scholar

5. WHO Consultation Report: Use of glycated hemoglobin (HbA1c) in the diagnosis of diabetes mellitus;www.who.int/diabetes/publications/report-hba1c_2011.pdf. Last Accessed on 27 April 2012. Search in Google Scholar

6. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 2010;33:562–8.10.2337/dc09-1524Search in Google Scholar PubMed PubMed Central

7. Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010;33:580–2.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275562700024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.2337/dc09-1843Search in Google Scholar PubMed PubMed Central

8. Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010;33:335–7.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275143700023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.2337/dc09-1357Search in Google Scholar PubMed PubMed Central

9. Kerner W, Brückel J. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie Stoffw 2011;6(Suppl 2):S107–10; in: Praxisempfehlungen der Deutschen Diabetes-Gesellschaft, Aktualisierte Version 2011, Hrsg.: M. Kellerer, S. Matthaei sowie im Internet: “Aktuelle Fassung der evidenzbasierten Leitlinien” www.deutsche-diabetes-gesellschaft.de oder www.diabetes-deutschland.de. Last Accessed on 27 April 2012.Search in Google Scholar

10. Kleinwechter H, Schäfer-Graf U, Bührer C, Hoesli I, Kainer F, Kautzky-Willer A, et al. Gestationsdiabetes mellitus (GDM) Evidenzbasierte Leitlinie zu Diagnostik, Therapie und Nachsorge der DDG und der DGGG. Diabetologie Stoffw 2011;6:290–328.10.1055/s-0031-1283757Search in Google Scholar

11. D'Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, et al. Approved IFCC Recommendation on Reporting Results for Blood Glucose (Abbreviated). Clin Chem 2005;51:1573–6.10.1373/clinchem.2005.051979Search in Google Scholar PubMed

12. Lackner K, Luppa PB, Koschinsky T, Danne T. Ein einheitlicher Kalibrationsbezug (Plasma statt Vollblut) bei der patientennahen Glukosebestimmung verbessert die Therapiesicherheit beim Einsatz von Glukosekonzentrationswert-abhängigen Therapiealgorithmen. Eine gemeinsame Initiative der DGKL, diabetesDE und der DDG (2009). Internet: http://www.deutsche-diabetes-gesellschaft.de/. Last Accessed on 27 April 2012.Search in Google Scholar

13. Koschinsky T, Junker R, Luppa PB, Schlebusch H. Improvement of therapeutic safety through standardized plasma calibration of blood glucose test systems at the point-of-care. J Lab Med 2009;33:349–52.10.1515/JLM.2009.058Search in Google Scholar

14. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International Association of Diabetes and Pregancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010;33:676–82.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275562700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

15. Colaguiri S, Sandbæk A, Carstensen B, Christensen J, Glumert C, Lauritzen T, et al. Comparability of venous and capillary glucose measurements in blood. Diabet Med 2003;20:953–6.10.1046/j.1464-5491.2003.01048.xSearch in Google Scholar PubMed

16. Haeckel R, Brinck U, Dubravka C, Janka H, Püntmann I, Schneider J, et al. Comparability of blood glucose concentration measured in different sample systems for detecting glucose intolerance. Clin Chem 2002;48:936–9.10.1093/clinchem/48.6.936Search in Google Scholar

17. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluorideas a preservative of glucose in blood. Clin Chem 1989;35:315–7.10.1093/clinchem/35.2.315Search in Google Scholar PubMed

18. Gambino R, Piscitelli J, Ackattupathil TA, Theriault JL, Andrin RD, Sanfilippo ML, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009;55:1019–21.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000265571900024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1373/clinchem.2008.121707Search in Google Scholar PubMed

19. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1–47.10.1373/clinchem.2010.161596Search in Google Scholar PubMed

20. Florkowski C, Budgen C, Kendall D, Lunt H, Moore MP. Comparison of blood glucose in a New Zealand diabetes centre. Ann Clin Biochem 2009;46:302–5.10.1258/acb.2009.008193http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269322600007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

21. Creed GM, Fox TJ, Beale RJ. Point-of care glucose monitoring in a critical care setting. Point of Care 2011;10:7–16.10.1097/POC.0b013e318207813bSearch in Google Scholar

22. Freckmann G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010;12:221–31.10.1089/dia.2009.0128Search in Google Scholar PubMed

23. Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL), Referenzinstitut für Bioanalytik (RfB), INSTAND e.V., Arbeitsgruppe POCT der DGKL und Verband der Diagnostica-Industrie (VDGH): Gemeinsame Stellungnahme zur Situation der Bewertung von Ringversuchen für Glukose mittels POCT-Systemen. 2012 (in press).Search in Google Scholar

24. Diabetes Risiko Test im Internet. http://www.dife.de/de/presse/Last Accessed on 27 April 2012.Search in Google Scholar

25. Beschluss des Gemeinsamen Bundesausschusses zum Screening auf Gestationsdiabetes mellitus im Internet: http://www.bvf.de/pdf/fachinfo/2011-12-15_Mu-RL_Screening_GDM.pdf. Last Accessed on 27 April 2012.Search in Google Scholar

Published Online: 2013-06-22
Published in Print: 2012-05-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Allergie und Autoimmunität/Allergy and Autoimmunity
  2. Moderne Komplementanalytik Indikationen – Methodik – Perspektiven/Modern complement analysis: indications, methods and outlook
  3. Modern complement analysis: indications, methods and outlook1),2)
  4. Autoantikörpernachweis mittels indirekter Immunfluoreszenz an HEp-2-Zellen1)/Autoantibody detection using indirect immunofluorescence on HEp-2 cells
  5. Birkenpollenassoziierte Sojaallergie: diagnostische Möglichkeiten und klinische Relevanz/Birch pollen associated soy allergy: possibilities in diagnostic and clinical relevance
  6. Birch pollen associated soy allergy – possibilities in diagnostic and clinical relevance1)
  7. Impact of image analysis software on quantitation of 1D gel electrophoresis analysis/Einfluss der Bildanalysesoftware auf die Bewertung von 1D Gelelektrophoresen
  8. Point-of-Care Testing
  9. „Neues und Kontroverses zur Blutglukosemessung bei der Diabetesdiagnostik: Konsequenzen der aktualisierten DDG- und AWMF-Leitlinien“/“Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG and AWMF guidelines”
  10. Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG (German Diabetes Society)- and AWMF (Association of the Scientific Medical Societies)-guidelines1)
  11. Gemeinsame Stellungnahme zur Situation der Bewertung von Ringversuchen für Glucose mittels Systemen f\xfcr die patientennahe Sofortdiagnostik (POCT)/Joint statement on the situation of external quality control for glucose in POCT systems
  12. Effektive Glykolyse-Inhibierung im Citrat-gepufferten venösen Vollblut und Plasma/Effective inhibition of glycolysis in venous whole blood and plasma samples
  13. Effective inhibition of glycolysis in venous whole blood and plasma samples1)
  14. Pädiatrisches Labor/Pediatric Laboratory Medicine
  15. Labordiagnostik bei Wachstumshormon-assoziierten Erkrankungen/Biochemical diagnosis of growth hormone related diseases
  16. Biochemical diagnosis of growth hormone related diseases1)
  17. Buchbesprechung/Book Review
  18. Protein Blotting and Detection. Methods and Protocols
  19. Kongressbericht/Congress Report
  20. XIIth International Congress of Paediatric Laboratory Medicine, Berlin, 13.-15. Mai 2011
  21. Masthead
  22. Masthead
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/labmed-2012-0008/html
Scroll to top button